<%@ Page Title="" Language="C#" MasterPageFile="~/masterpages/moduleGerman.master" AutoEventWireup="true" CodeFile="references-at.aspx.cs" Inherits="secure_modules_module5_references_at" %>

<asp:Content ID="Content1" ContentPlaceHolderID="contentBreadcrumb" Runat="Server">
    Pflege und Betreuung \ Alle Referenzen
</asp:Content>
<asp:Content ID="Content2" ContentPlaceHolderID="contentSideBar" Runat="Server">
</asp:Content>
<asp:Content ID="Content3" ContentPlaceHolderID="contentMain" Runat="Server">
    <div class="module5page">
        <h1>
            Referenzen</h1>
             <div class="icon_reading">
        <ul class="references">
            <li><span>National Collaboration Centre for Chronic Conditions (NCCCC). Multiple Sclerosis.
                Royal College of Physicians London. 2004 </span></li>
            <li><span>Forbes A, While, A, Taylor M. What people with multiple sclerosis perceive
                to be important to meeting their needs. <i>J Adv Nurs</i> 2007; 58(1): 11−22. </span>
            </li>
            <li><span>Pakenham KI. Relations between coping and positive and negative outcomes in
                carers of persons with multiple sclerosis (MS). <i>J Clin Psychol Med Settings</i>
                2005; 12(1): 25 – 38. </span></li>
            <li><span>MS Society. Caring for someone with MS: a handbook for family and friends.
                2nd edition, July 2009. </span></li>
            <li><span>McKeown LP, Porter-Armstrong AP, Baxter GD. The needs and experiences of caregivers
                of individuals with multiple sclerosis: a systematic review. <i>Clin Rehabil</i>
                2003; 17: 234–48. </span></li>
            <li><span>Figved N, Myhr KM, Larsen JP, <i>et al.</i> Caregiver burden in multiple sclerosis:
                the impact of neuropsychiatric symptoms. <i>J Neurol Neurosurg Psychiatry</i> 2007;
                78(10): 1097–102. </span></li>
            <li><span>Aymerich M, Guillamón I, Jovell AJ. Health-related quality of life assessment
                in people with multiple sclerosis and their family caregivers. A multicentre study
                in Catalonia (southern Europe). <i>Patient Prefer Adherence</i> 2009; 3: 311–21.
            </span></li>
            <li><span>In Sickness and in Health, June 2012: Available at <a href="http://carersweek.org/about-carers/in-sickness-and-in-health">
                http://carersweek.org/about-carers/in-sickness-and-in-health</a> </span></li>
            <li><span>Nolan M. Working with family carers: towards a partnership approach. <i>Rev
                Clin Gerontol</i> 2001; 11(1): 91–97. </span></li>
            <li><span>Saunders C, Caon C, Smrtka J, <i>et al.</i> Factors that influence adherence
                and strategies to maintain adherence to injected therapies for patients with multiple
                sclerosis. <i>J Neurosci Nurs</i> 2010; 42(5 Suppl): S10–8. </span></li>
            <li><span>Plow MA, Finlayson M, Rezac M. A scoping review of self-management interventions
                for adults with multiple sclerosis. <i>PM R</i> 2011; 3(3): 251–62. </span></li>
            <li><span>Smrtka J, Caon C, Saunders C, <i>et al.</i> Enhancing adherence through education.
                <i>J Neurosci Nurs</i> 2010; 42(5 Suppl): S19−29. </span></li>
            <li><span>Heesen C, Solari A, Giordano A, <i>et al.</i> Decisions on multiple sclerosis
                immunotherapy: New treatment complexities urge patient engagement. <i>J Neurol Sci</i>
                2011; 306(1–2): 192–7. </span></li>
            <li><span>Ben-Zacharia A, Lublin F. Talking about initiating and adhering to treatment
                with injectable disease modifying agents. National MS Society. 2009. Available at
                <a href="www.nationalmssociety.org/download.aspx?id=180">www.nationalmssociety.org/download.aspx?id=180</a>
                Accessed January 14, 2012. </span></li>
            <li><span>Costello K and Halper J. Multiple Sclerosis: Key issues in Nursing Management
                – Adherence, Cognitive Function, Quality of Life. 3rd ed. Washington, DC: Expert
                Medical Education; 2010: 9–20. </span></li>
            <li><span>Consortium of Multiple Sclerosis Centers (CMSC). Comprehensive Care in Multiple
                Sclerosis. 2010. </span></li>
            <li><span>Harris C, Costello K, Halper J, <i>et al.</i> Consortium of Multiple Sclerosis
                Centers Recommendations for Care of Those Affected by Multiple Sclerosis. <i>Int J MS
                    Care</i> 2003; 5(3): 67–78. </span></li>
            <li><span>MS Mentor number 3 </span></li>
            <li><span>Barlow J, Turner A, Edwards R, <i>et al.</i> A randomised controlled trial
                of lay-led self management for people with multiple sclerosis. <i>Patient Educ Couns</i>
                2009; 77(1): 81–9 </span></li>
            <li><span>Johnson J. On receiving the diagnosis of MS: Managing the transition. <i>Mult
                Scler</i> 2003; 9: 82–8. </span></li>
            <li><span>Halper J, Costello K, Harris C. Nursing Practice in Multiple Sclerosis, A
                Core Curriculum. Second Edition. Demos Medical Publishing 2003 </span></li>
            <li><span>National MS Society Professional Resource Centre. MS: Focus on Rehabilitation.
                4th edition 2010. </span></li>
            <li><span>Vickrey BG, Shatin D, Wolf SM, <i>et al.</i> Management of multiple sclerosis
                across managed care and fee-for-service systems. <i></i>Neurology</i> 2000; 55(9):
                1341–9. </span></li>
            <li><span>Ytterberg C, Johansson S, Gottberg K, Holmqvist LW, von Koch L. Perceived
                needs and satisfaction with care in people with multiple sclerosis: A two-year prospective
                study. <i>BMC Neurology</i> 2008; 8: 36. </span></li>
            <li><span>Feinstein A. Multiple sclerosis and depression. <i>Mult Scler</i> 2011; 17(11):
                1276–81. </span></li>
            <li><span>Schiffer R, Arnett P, Benedict R, <i>et al.</i> The Goldman consensus statement
                on depression in multiple sclerosis. <i>Mult Scler</i> 2005; 11: 328–37. </span>
            </li>
            <li><span>Cetin K, Johnson KL, Ehde DM, <i>et al.</i> Antidepressant use in multiple
                sclerosis: epidemiologic study of a large community sample. <i>Mult Scler</i> 2007;
                13(8): 1046–53. </span></li>
            <li><span>National Institute for Health and Clinical Excellence (NICE). Depression in
                adults with a chronic physical health problem: treatment and management. NICE Clinical
                Guideline 91. London: NICE; 2009. </span></li>
            <li><span>Bamer AM, Cetin K, Johnson KL, <i>et al.</i> Validation study of prevalence
                and correlates of depressive symptomatology in multiple sclerosis. <i>Gen Hosp Psychiatry</i>
                2008; 30(4): 311–7. </span></li>
            <li><span>Multiple Sclerosis Information for Health and Social Care Professionals. MS
                Trust, 4th edition; 2011 </span></li>
            <li><span>Feinstein A. An examination of suicide intent in patients with multiple sclerosis.
                <i>Neurology</i> 2002; 59(59): 674–8. </span></li>
            <li><span>Giannini MJ, Bergmark B, Kreshover S, <i>et al.</i> Understanding suicide
                and disability through three major disabling conditions: Intellectual disability,
                spinal cord injury, and multiple sclerosis. <i>Disabil Health J</i> 2010; 3(2):
                74–8. </span></li>
            <li><span>Mohr DC, Boudewyn AC, Goodkin DE, <i>et al.</i> Comparative outcomes for individual
                cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline
                for the treatment of depression in multiple sclerosis. <i>J Consult Clin Psychol</i>
                2001; 69(6): 942–9. </span></li>
            <li><span>Walker ID and Gonzalez EW. Review of intervention studies on depression in
                persons with multiple sclerosis. <i>Issues Ment Health Nurs</i> 2007; 28(5): 511–31.
            </span></li>
            <li><span>Korostil M and Feinstein A. Anxiety disorders and their clinical correlates
                in multiple sclerosis patients. <i>Mult Scler</i> 2007; 13(1): 67–72. </span>
            </li>
            <li><span>Bruce JM and Arnett P. Clinical correlates of generalized worry in multiple
                sclerosis. <i>J Clin Exp Neuropsychol</i> 2009; 31(6): 698–705. </span></li>
            <li><span>Wood B, van der Mei I, Ponsonby AL, <i>et al.</i> Prevalence and concurrence
                of anxiety, depression and fatigue over time in multiple sclerosis. <i>Mult Scler</i>
                2012 Jun 22. [Epub ahead of print] </span></li>
            <li><span>Chwastiak LA and Ehde DM. Psychiatric issues in multiple sclerosis. <i>Psychiatr
                Clin North Am</i> 2007; 30(4): 803–17. </span></li>
            <li><span>Poder K, Ghatavi K, Fisk JD, <i>et al.</i> Social anxiety in a multiple sclerosis
                clinic population. <i>Mult Scler</i> 2009; 15(3): 393–8. </span></li>
            <li><span>Artemiadis AK, Anagnostouli MC, Alexopoulos EC. Stress as a risk factor for
                multiple sclerosis onset or relapse: a systematic review. <i>Neuroepidemiology</i>
                2011; 36(2): 109–20. </span></li>
            <li><span>José Sá M. Psychological aspects of multiple sclerosis. <i>Clin Neurol Neurosurg</i>
                2008; 110(9): 868–77 </span></li>
            <li><span>McCabe MP, McKern S, McDonald E. Coping and psychological adjustment among
                people with multiple sclerosis. <i>J Psychosom Res</i> 2004; 56(3): 355–61 </span>
            </li>
            <li><span>Mueller P. Religious involvement, spirituality and medicine: subject review
                and implications for clinical practice. In: Oken BS, ed. <i>Complementary Therapies
                    in Neurology</i>. London: Parthenon Publishing, 2004, p. 189–207 </span>
            </li>
            <li><span>Bowling AC. <i>Complementary and Alternative Medicine and Multiple Sclerosis</i>.
                New York: Demos Medical Publishing, 2007, p. 190-194. </span></li>
            <li><span>Grossman P, Kappos L, Gensicke H, <i>et al.</i> MS quality of life, depression,
                and fatigue improve after mindfulness training: a randomized trial. <i>Neurology</i>
                2010; 75(13): 1141–9. </span></li>
            <li><span>Dennison L, Moss-Morris R, Chalder T. A review of psychological correlates
                of adjustment in patients with multiple sclerosis. <i>Clin Psychol Rev</i> 2009;
                29(2): 141–53. </span></li>
            <li><span>Jarrett L. Provision of education and promoting self-management. In: Stevenson
                VL, Jarrett L, editors. <i>Spasticity management: a practical multidisciplinary guide</i>.
                London: Informa Healthcare; 2006. p. 27-36. </span></li>
            <li><span>Currie R. Spasticity: A common symptom of multiple sclerosis. <i>Nurs Stand</i>
                2001; 15(33): 47–52. </span></li>
            <li><span>Sauter C, Zebenholzer K, Hisakawa J, <i>et al.</i> A longitudinal study on
                effects of a six-week course for energy conservation for multiple sclerosis patients.
                <i>Mult Scler</i> 2008; 14(4): 500–5. </span></li>
            <li><span>Mathiowetz VG, Finlayson ML, Matuska KM, Chen HY, Luo P. Randomized controlled
                trial of an energy conservation course for persons with multiple sclerosis. <i>Mult
                    Scler</i> 2005; 11(5): 592–601. </span></li>
            <li><span>Cohen BA. Identification, causation, alleviation, and prevention of complications
                (ICAP). An approach to symptom and disability management in multiple sclerosis.
                <i>Neurology</i> 2008; 71(24 Suppl 3): S14–20. </span></li>
            <li><span>Wiles CM, Newcombe RG, Fuller KJ, <i>et al.</i> Controlled randomised crossover
                trial of the effects of physiotherapy on mobility in chronic multiple sclerosis.
                <i>J Neurol Neurosurg Psychiatry</i> 2001; 70(2): 174–9. </span></li>
            <li><span>Mostert S and Kesselring J. Effects of a short-term exercise training program
                on aerobic fitness, fatigue, health perception and activity level of subjects with
                multiple sclerosis. <i>Mult Scler</i> 2002; 8(2): 161–8. </span></li>
            <li><span>Oken BS, Kishiyama S, Zajdel D, <i>et al.</i> Randomized controlled trial
                of yoga and exercise in multiple sclerosis. <i>Neurology</i> 2004; 62(11): 2058–64.
            </span></li>
            <li><span>Schwid SR, Petrie MD, Murray R, <i>et al.</i> A randomized controlled study
                of the acute and chronic effects of cooling therapy for MS. <i>Neurology</i> 2003;
                60(12): 1955–60. </span></li>
            <li><span>Dalgas U, Stenager E, Jakobsen J, <i>et al.</i> Fatigue, mood and quality
                of life improve in MS patients after progressive resistance training. <i>Mult Scler</i>
                2010; 16(4): 480–90. </span></li>
            <li><span>Finlayson M, Preissner K, Cho C, <i>et al.</i> <a href="http://www.ncbi.nlm.nih.gov/pubmed/21561960">
                Randomized trial of a teleconference-delivered fatigue management program for people
                with multiple sclerosis</a>. <i>Mult Scler</i> 2011; 17(9): 1130–40. </span>
            </li>
            <li><span>Martin CL, Phillips BA, Kilpatrick TJ, <i>et al.</i> Gait and balance impairment
                in early multiple sclerosis in the absence of clinical disability. <i>Mult Scler</i>
                2006; 12(5): 620–8. </span></li>
            <li><span>National Multiple Sclerosis Society (NMSS). Cognitive function. Accessed January
                25, 2012 at:http://www.nationalmssociety.org/about-multiple-sclerosis/what-we-knowabout-ms/symptoms/cognitive-function/index.aspx
            </span></li>
            <li><span>Schiffer RB. National Multiple Sclerosis Society. Cognitive loss in multiple
                sclerosis. Available online at: http://www.nationalmssociety.org/for-professionals/healthcare
                professionals/publications/clinical-bulletins/download.aspx?id=173 (Accessed January
                25, 2012). </span></li>
            <li><span>Benedict RH, Duquin JA, Jurgensen S, <i>et al.</i> Repeated assessment of
                neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities
                Test and the MS Neuropsychological Screening Questionnaire. <i>Mult Scler</i> 2008;
                14(7): 940–6. </span></li>
            <li><span>Parmenter BA, Weinstock-Guttman B, Garg N, <i>et al.</i> Screening for cognitive
                impairment in multiple sclerosis using the Symbol digit Modalities Test. <i>Mult Scler</i>
                2007; 13(1): 52–7. </span></li>
            <li><span>Sumowski JF, Wylie GR, Chiaravalloti N, <i>et al.</i> Intellectual enrichment
                lessens the effect of brain atrophy on learning and memory in multiple sclerosis.
                <i>Neurology</i> 2010; 75(21): 1942–5. </span></li>
            <li><span>National Multiple Sclerosis Society (NMSS). Assessment and management of cognitive
                impairment in multiple sclerosis. Accessed January 25, 2012 at: http://www.nationalmssociety.org/for-professionals/healthcareprofessionals/publications/expert-opinion
                papers/download.aspx?id=124. </span></li>
            <li><span>O'Brien AR, Chiaravalloti N, Goverover Y, <i>et al.</i> Evidenced-based cognitive
                rehabilitation for persons with multiple sclerosis: a review of the literature.
                <i>Arch Phys Med Rehabil</i> 2008; 89(4): 761–9. </span></li>
            <li><span>Basso MR, Ghormley C, Lowery N, <i>et al.</i> Self-generated learning in people
                with multiple sclerosis: an extension of Chiaravalloti and DeLuca (2002). <i>J Clin
                    Exp Neuropsychol</i> 2008; 30(1): 63–9. </span></li>
            <li><span>Brenk A, Laun K, Haase CG. Short-term cognitive training improves mental efficiency
                and mood in patients with multiple sclerosis. <i>Eur Neurol</i> 2008; 60(6): 304–9.
            </span></li>
            <li><span>Chiaravalloti ND and DeLuca J. Cognitive impairment in multiple sclerosis.
                <i>Lancet Neurol</i> 2008; 7(12): 1139–51. </span></li>
            <li><span>Nortvedt MW, Riise T, Myhr KM, <i>et al.</i> Reduced quality of life among
                multiple sclerosis patients with sexual disturbance and bladder dysfunction. <i>Mult
                    Scler</i> 2001; 7(4); 231–5. </span></li>
            <li><span>Motta R and de Carvalho ML. Management of bladder dysfunction in multiple
                sclerosis patients: the nurse's point of view. <i>Neurol Sci</i> 2008; 29 Suppl
                4: S356–9. </span></li>
            <li><span>Fowler CJ, Panicker JN, Drake M, <i>et al.</i> UK consensus on the management
                of the bladder in multiple sclerosis. <i>Postgrad Med J</i> 2009; 85(1008): 552–9.
            </span></li>
            <li><span>Norton C and Chelvanayagam S. Bowel problems and coping strategies in people
                with multiple sclerosis. <i>Br J Nurs</i> 2010; 19(4): 220–6. </span></li>
            <li><span>Wiesel PH, Norton C, Glickman S, <i>et al.</i> Pathophysiology and management
                of bowel dysfunction in multiple sclerosis. <i>Eur J Gastroenterol Hepatol</i> 2001;
                13(4): 441–8. </span></li>
            <li><span>Stevenson V and Jarrett L. Spasticity management: A practical multidisciplinary
                guide. Oxford: Informa Health Care; 2006. </span></li>
            <li><span>Jarrett L. The nurse’s role in assessing and measuring spasticity. <i>Nurs
                Times</i> 2006; 102(15): 26–8. </span></li>
            <li><span>Multiple Sclerosis Council for Clinical Practice Guidelines (MSCCPG) and Consortium
                of Multiple Sclerosis Centers (CMSC). Spasticity Management in Multiple Sclerosis.
                Accessed January 25, 2012 at: http://www.mscare.org/cmsc/images/pdf/spasticityguidelines_2005.pdf.
            </span></li>
            <li><span>Thompson AJ, Jarrett L, Lockley L. Clinical management of spasticity. <i>J
                Neurol Neurosurg Psychiatry</i> 2005; 76(4): 459–63. </span></li>
            <li><span>Perrin Ross A. <i>Counseling Points</i>: Practical approaches to spasticity
                management. Summer 2009 </span></li>
            <li><span>Brown TR and Kraft GH. Exercise and rehabilitation for individuals with multiple
                sclerosis. <i>Phys Med Rehabil Clin N Am</i> 2005; 16(2): 513–55 </span></li>
            <li><span>Bermejo PE, Oreja-Guevara C, Díez-Tejedor E. Pain in multiple sclerosis: prevalence,
                mechanisms, types and treatment. <i>Rev Neurol</i> 2010; 50: 101–8. </span></li>
            <li><span>National Institute for Clinical Excellence (NICE). Multiple Sclerosis- Management
                of multiple sclerosis in primary and secondary care. NICE Clinical Guideline 8.
                London: NICE; 2003. </span></li>
            <li><span>Henze, T. Managing specific symptoms in people with multiple sclerosis. <i>
                Int MS J</i> 2005; 12(2): 60–8. </span></li>
            <li><span>Pöllmann W, Feneberg W, Steinbrecher A, <i>et al.</i> Therapy of pain syndromes
                in multiple sclerosis—an overview with evidence-based recommendations. <i>Fortschr Neurol
                    Psychiatr</i> 2005; 73(5): 268–85. </span></li>
            <li><span>Solaro C, Lunardi GL, Mancardi GL. Pain and MS. <i>Int MS J</i> 2003; 10(1):
                14–9. </span></li>
            <li><span>Allman RM. Pressure ulcer prevalence, incidence, risk factors and impact.
                <i>Clin Geriatr Med</i> 1997; 13(3): 421–36. </span></li>
            <li><span>Grey JE, Harding KG, Enoch S. Pressure ulcers. <i>BMJ</i> 2006; 332(7539):
                472–5. </span></li>
            <li><span>European Pressure Ulcer Advisory Panel and National Pressure Ulcer Advisory
                Panel. Pressure ulcer prevention: quick reference guide. Washington DC: National
                Pressure Ulcer Advisory; 2009. </span></li>
            <li><span>National Institute for Health and Clinical Excellence. The management of pressure
                ulcers in primary and secondary care. NICE Clinical Guideline 29. London: NICE;
                2005. </span></li>
            <li><span>Rycroft-Malone J, McInnes E. Pressure ulcer risk assessment and prevention.
                Technical Report. London; RCN: 2000 </span></li>
            <li><span>Perrin Ross A. <i>Counseling Points</i>: Managing comorbidities in MS. Summer
                2011 </span></li>
            <li><span>Cantorna MT. Vitamin D, multiple sclerosis and inflammatory bowel disease.
                <i>Arch Biochem Biophys</i> 2011; 523(1): 103–6. </span></li>
            <li><span>Lucas RM, Ponsonby AL, Dear K, <i>et al.</i> Current and past Epstein-Barr
                virus infection in risk of initial CNS demyelination. <i>Neurology</i> 2011; 77(4):
                371–9. </span></li>
            <li><span>Weinstock-Guttman B, Zivadinov R, Qu J, <i>et al.</i> Vitamin D metabolites
                are associated with clinical and MRI outcomes in multiple sclerosis patients. <i>J Neurol
                    Neurosurg Psychiatry</i> 2011; 82(2): 189–95. </span></li>
            <li><span>Stuifbergen A and Becker H. Health Promotion practices in women with multiple
                sclerosis: Increasing quality and years of healthy life. <i>Phys Med Rehabil Clin N
                    Am</i> 2001; 12(1): 9–22. </span></li>
            <li><span>Marrie RA, Cutter G, Tyry T, <i>et al.</i> A cross-sectional study of bone
                health in multiple sclerosis. <i>Neurology</i> 2009; 73(17): 1394–8. </span>
            </li>
            <li><span>Hearn AP and Silber E. Osteoporosis in multiple sclerosis. <i>Mult Scler</i>
                2010; 16(9): 1031–43. </span></li>
            <li><span>Weinstock-Guttman B, Gallagher E, Baier M, <i>et al.</i> Risk of bone loss
                in men with multiple sclerosis. <i>Mult Scler</i> 2004; 10(2): 170–175. </span>
            </li>
            <li><span>Bakker A, Klein-Nulend J, Burger E. Shear stress inhibits while disuse promotes
                osteocyte apoptosis. <i>Biochem Biophys Res Commun</i> 2004; 320(4): 1163–8. </span>
            </li>
            <li><span>Tan SD, de Vries TJ, Kuijpers-Jagtman AM, <i>et al.</i> Osteocytes subjected
                to fluid flow inhibit osteoclast formation and bone resorption. <i>Bone</i> 2007;
                41(5): 745–51. </span></li>
            <li><span>Zikan V. Bone health in patients with multiple sclerosis. <i>J Osteoporos</i>
                2011; 2011: 596294. </span></li>
            <li><span>Koch M, De Keyser J, Tremlett H. Timing of birth and disease progression in
                multiple sclerosis. <i>Mult Scler</i> 2008; 14(6): 793-8. </span></li>
            <li><span>Dwosh E, Guimond C, Sadovnick AD. Reproductive counselling in MS: a guide
                for healthcare professionals. <i>Int MS J</i> 2003; 10(2): 67. </span></li>
            <li><span>Stuart M and Bergstrom L. Pregnancy and multiple sclerosis. <i>J Midwifery
                Womens Health</i> 2011; 56(1): 41–7. </span></li>
            <li><span>Cook SD. Multiple Sclerosis. In. Hainline, and Devinsky (Eds). <i>Advances
                in Neurology Vol. 90. Neurological Complications of Pregnancy</i>, (2nd ed.) (p.
                135–144) Philadelphia: Lippincott Williams and Wilkins; 2002. </span></li>
            <li><span>Confavreux C, Hutchinson M, Hours MM, <i>et al.</i> Rate of pregnancy related
                relapse in multiple sclerosis. <i>N Engl J Med</i> 1998; 339: 285–91. </span>
            </li>
            <li><span>Weinshenker BG, Hader W, Carriere W, <i>et al.</i> The influence of pregnancy
                on disability from multiple sclerosis: A population based study in Middlesex County,
                Ontario. <i>Neurology</i> 1989; 39, 1438–40. </span></li>
            <li><span>Vukusic S, Hutchinson M, Hours M, <i>et al.</i> Pregnancy and multiple sclerosis
                (the PRIMS study): clinical predictors of postpartum relapse. <i>Brain</i> 2004;
                127(Pt 6): 1353–60. </span></li>
            <li><span>Ferrero S, Pretta S, Ragni N. Multiple Sclerosis: Management issues during
                pregnancy. <i>Eur J Obstet Gynecol Reprod Biol</i> 2004; 115(1): 3–9. </span>
            </li>
            <li><span>Franklin GM and Tremlett H. Multiple sclerosis and pregnancy: What should
                we be telling our patients? <i>Neurology</i> 2009; 73(22): 1820–2. </span></li>
            <li><span>Smith R and Studd JW. A pilot study of the effect upon multiple sclerosis
                of the menopause, hormone replacement therapy and the menstrual cycle. <i>J R Soc Med</i>
                1992; 85(10): 612–3. </span></li>
            <li><span>Zorgdrager A and De Keyser J. Menstrually related worsening symptoms in multiple
                sclerosis. <i>J Neurol Sci</i> 1997; 149(1): 95–7. </span></li>
            <li><span>Houtchens MK, Gregori N, Rose JW. Understanding fluctuations of multiple sclerosis
                across the menstrual Cycle. <i>Int J MS Care</i> 2000; 2(4): 7–14. </span></li>
            <li><span>Wilson S. Premenstrual worsening of MS symptoms. <i>Way Ahead</i> 2001; 5(3):
                14. </span></li>
            <li><span>Coyle PK and Halper J. Meeting the challenge of progressive multiple sclerosis.
                New York; Demos Medical Publishing: 2001. p93. </span></li>
            <li><span>Zorgdrager A and De Keyser J. The premenstrual period and exacerbations in
                multiple sclerosis. <i>Eur Neurol</i> 2002; 48(4): 204–6. </span></li>
            <li><span>Holmqvist P, Wallberg M, Hammar M, <i>et al.</i> Symptoms of multiple sclerosis
                in women in relation to sex steroid exposure. <i>Maturitas</i> 2006; 54(2): 149–53.
            </span></li>
            <li><span>Tomassini V, Onesti E, Mainero C, <i>et al.</i> Sex hormones modulate brain
                damage in multiple sclerosis: MRI evidence. <i>J Neurol Neurosurg Psychiatry</i>
                2005; 76(2): 272–5. </span></li>
            <li><span>Katz A. Multiple sclerosis and sexuality. <i>Am J Nurs</i> 2011; 111(7): 65–8
            </span></li>
            <li><span>Bronner G, Elran E, Golomb J, <i>et al.</i> Female sexuality in multiple sclerosis:
                the multidimensional nature of the problem and the intervention. <i>Acta Neurol Scand</i>
                2010; 121(5): 289–301. </span></li>
            <li><span>Annon JS. Behavioral treatment of sexual problems. New York: Harper and Row;
                1976. </span></li>
            <li><span>Taylor B and Davis S. Using the Extended PLISSIT model to address healthcare
                needs. <i>Nurs Stand</i> 2006; 21(11): 35–40. </span></li>
            <li><span>Office of Disease Prevention and Health Promotion, U.S. Department of Health
                and Human Services. Healthy People 2010. Online: http://www.healthypeople.gov/2010/
            </span></li>
            <li><span>Stuifbergen AK, Morris M, Jung JH, <i>et al.</i> Benefits of wellness interventions
                for persons with chronic and disabling conditions: a review of the evidence. <i>Disabil
                    Health J</i> 2010; 3(3): 133–45. </span></li>
            <li><span>Karpatkin H. Exercise in multiple sclerosis: a review of the evidence. <i>
                Int J MS Care</i> 2005; 7: 36–41. </span></li>
            <li><span>Hernán MA, Olek MJ, Ascherio A. Cigarette smoking and the incidence of multiple
                sclerosis. <i>Am J Epidemiol </i>2001; 154(1): 69–74. </span></li>
            <li><span>Hawkes CH. Smoking is a risk factor for multiple sclerosis: a meta analysis.
                <i>Mult Scler</i> 2007; 13(5): 610–5. </span></li>
            <li><span>Hernán MA, Jick SS, Logroscino G, <i>et al.</i> Cigarette smoking and the
                progression of multiple sclerosis. <i>Brain</i> 2005; 128(Pt 6): 1461–5. </span>
            </li>
            <li><span>Pittas F, Ponsonby AL, van der Mei IA, <i>et al.</i> Smoking is associated
                with progressive disease course and increased progression in clinical disability
                in a prospective cohort of people with multiple sclerosis. <i>J Neurol</i> 2009;
                256(4): 577–85. </span></li>
            <li><span>Healy BC, Ali EN, Guttmann CR, <i>et al.</i> Smoking and disease progression
                in multiple sclerosis. <i>Arch Neurol</i> 2009; 66(7): 858–64. </span></li>
            <li><span>Mikaeloff Y, Caridade G, Tardieu M, <i>et al.</i> Parental smoking at home
                and the risk of childhood-onset multiple sclerosis in children. <i>Brain</i> 2007;
                130(Pt 10): 2589–95. </span></li>
            <li><span>Shirani A and Tremlett H. The effect of smoking on the symptoms and progression
                of multiple sclerosis: a review. <i>J Inflamm Res</i> 2010; 3: 115–26. </span>
            </li>
            <li><span>Dalmay F, Bhalla D, Nicoletti A, <i>et al.</i> Multiple sclerosis and solar
                exposure before the age of 15 years: case-control study in Cuba, Martinique and
                Sicily. <i>Mult Scler</i> 2010; 16(8): 899–908. </span></li>
            <li><span>Munger KL, Levin LI, Hollis BW, <i>et al.</i> Serum 25-hydroxyvitamin D levels
                and risk of multiple sclerosis. <i>JAMA</i> 2006; 296(23): 2832–8. </span></li>
            <li><span>Simpson S Jr, Taylor B, Blizzard L, <i>et al.</i> Higher 25-hydroxyvitamin
                D is associated with lower relapse risk in multiple sclerosis. <i>Ann Neurol</i>
                2010; 68(2): 193–203. </span></li>
            <li><span>Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. <i>Lancet
                Neurol</i> 2010; 9(6): 599–612. </span></li>
            <li><span>Zwibel HL and Smrtka J. Improving quality of life in multiple sclerosis: An
                unmet need. <i>Am J Man Care</i> 2011; 17(Suppl 5): S139–45. </span></li>
            <li><span>Ivanova JI, Birnbaum HG, Samuels S, <i>et al.</i> The cost of disability and
                medically related absenteeism among employees with multiple sclerosis in the US.
                <i>Pharmacoeconomics</i> 2009; 27(8): 681–91. </span></li>
            <li><span>McCabe MP and De Judicibus M. Multiple sclerosis and economic well-being:
                role of health, age, and duration of illness. <i>J Clin Psychol Med Settings</i>
                2003; 10(3): 139–47. </span></li>
            <li><span>Dennett SL, Castelli-Haley J, Oleen-Burkey MK. The impact of multiple sclerosis
                on patient employment: a review of the medical literature. <i>JHP</i> 2007; 2(2):
                12–18. </span></li>
            <li><span>Lauer K and Firnhaber W. Epidemiological investigations into multiple sclerosis
                in southern Hesse. V. Course and prognosis. <i>Acta Neurol Scand</i> 1987; 76(1):
                12-7. </span></li>
            <li><span>Bevan S, Zheltoukhova K, McGee R, <i>et al.</i> Ready to Work? Meeting the
                Employment and Career Aspirations of People with Multiple Sclerosis. <i>Work Foundation</i>
                2011. </span></li>
            <li><span>Busche KD, Fisk JD, Murray TJ, <i>et al.</i> Short term predictors of unemployment
                in multiple sclerosis patients. <i>Can J Neurol Sci</i> 2003; 30(2): 137–42. </span>
            </li>
            <li><span>Beatty W, Blanco C, Wilbanks S, <i>et al.</i> Demographic, clinical and cognitive
                characteristics of multiple sclerosis patients who continue to work. <i>Neurorehabil
                    Neural Repair</i> 1995; 9(3): 167–73. </span></li>
            <li><span>Genevie L, Kallos JE, Struening EL. Job retention among people with MS. <i>
                Neurorehabil Neural Repair</i> 1987; 1(3): 131–5. </span></li>
            <li><span>Multiple Sclerosis International Foundation (MSIF). MSIF Survey on employment
                in MS. April 2010. Available at www.msif.org/document.rm?id=648 </span></li>
            <li><span>Masters WH and Johnson VE. Human sexual response. London: J & A Churchill
                Ltd; 1966. </span></li>
            <li><span>Chandler BJ and Brown S. Sex and relationship dysfunction in neurological
                disability. <i>J Neurol Neurosurg Psychiatry</i> 1998; 65(6): 877–80. </span>
            </li>
            <li><span>Halvorson JG and Metz ME. Sexual dysfunction, part 1: Classification, etiology
                and pathogenesis. <i>J Am Board Fam Pract</i> 1992; 5(1): 51–61. </span></li>
            <li><span>Abrams KS. The impact on marriages of adult-onset paraplegia. <i>Paraplegia</i>
                1981; 19(4): 253–9. </span></li>
            <li><span>Woollett SL and Edelmann RJ. Marital satisfaction in individuals with multiple
                sclerosis and their partners; its interactive effect with life satisfaction, social
                networks and disability. <i>Sex Marital Therapy</i> 1988; 3(2): 191–6. </span>
            </li>
            <li><span>International Organisation of MS Nurses (IOMSN). MS: A Nursing Update. 2010
            </span></li>
            <li><span>Purnell L, & Paulanka B. (1998). Transcultural health care: A culturally competent
                approach. Philadelphia: FA Davis. </span></li>
            <li><span>Huber L. Making community healthcare culturally correct. <i>American Nurse
                Today</i> 2009; 4(5): 13–15. </span></li>
            <li><span>Halper and Holland. Comprehensive nursing care in MS, 3rd edition 2011. </span>
            </li>
        </ul>
        </div>
    </div>
</asp:Content>

